Effect of a Coordinated Primary-care-Based MDT-model on the Treatment of Hard-to-heal Ulcers
TSS
1 other identifier
interventional
80
1 country
1
Brief Summary
The TSS project is a study of the effects of treating hard-to-heal ulcers in a multidisciplinary cross sectional team, meaning that nurse and doctor from a hospital based wound healing clinic and wound care nurse from the primary care sector treat the patient in collaboration rather than the current form where care in municipalities and hospital setting, communicate but treat the patient on their own. The study is designed as a randomized study, meaning that individuals with hard-to-heal ulcers are randomly designated to standard care or the multidis-ciplinary team. We measure several aspects of the new format, but the main outcome com-pared between the two groups (standard care and multidisciplinary care) is number of ulcers healed. Participants are followed for a year after inclusion in the study, and have 6 fixed visits in the clinic, with the possibility of more visits if necessary. There is no "new" medicine, surgery or other treatments planned in the study, but the multi-disciplinary team can offer and implement any treatment deemed appropriate for the individ-ual that is allocated to the multidisciplinary team, of course the individual has the opportunity to decline any treatment offered by the team. The control group, i.e. individuals allocated to standard care, will receive the treatment that is normally available to individuals with hard-to-heal ulcers treated in the municipality, including referral to hospital based treatments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedFirst Posted
Study publicly available on registry
August 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 31, 2028
August 5, 2026
July 1, 2026
9 months
July 9, 2026
August 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ulcer healing
Number of individuals that achieve healing of their hard-to-heal ulcer(s), compared between two arms
Ulcer healing at 12 months
Secondary Outcomes (13)
Time to ulcer healing
12 moths
Ulcer recurrence
12 months
Infections
12 months
Amputations
12 months
Visits
12 months
- +8 more secondary outcomes
Study Arms (2)
coordinated primary-care-based MDT-model
EXPERIMENTALThe proposed intervention consists of an MDT with an orthopedic surgeon (Jonas Askø Andersen) and a wound care nurse from the wound clinical at North Zealand Hospital as well as a wound care nurse from the primary sector. Participants who are randomized to intervention is offered treatment in the team as deemed appropriate by the MDT. The participant will be seen in the clinic (in the primary sector) for planned study visits at. 1\. Week 1 2. Week 4 3. 3 months 4. 6 months 5. 12 months 6. Extra study visits can be planned as deemed necessary for the individual participant between the above outlined visits Weekly visits in the clinic for bandage changes and standard wound care is planned as deemed relevant by the MDT team for the individual participant. The visits are performed by wound care nurses in the primary sector If any outcomes relevant for the study occurs outside of the planned study visits i.e., ulcer healing, infections or recurrence following healing, the participant is pla
Standard Care
ACTIVE COMPARATORParticipants randomized to control are not invited to be seen by the MDT team but are attended by the wound care nurse from the primary sector as part of the standard treatment offered to individuals with ulcers in the municipality. Apart from planned visits at 3, 6 and 12 months, the frequency and number of visits in the study period is performed as deemed appropriate by the wound care nurses from the primary sector. If any outcomes relevant for the study occurs outside of the planned study visits i.e., ulcer healing, infections or recurrence following healing date of event is noted.
Interventions
The proposed intervention consists of an MDT with an orthopedic surgeon (Jonas Askø Andersen) and a wound care nurse from the wound clinical at North Zealand Hospital as well as a wound care nurse from the primary sector. Participants who are randomized to intervention is offered treatment in the team as deemed appropriate by the MDT. The participant will be seen in the clinic (in the primary sector) for planned study visits at. 1\. Week 1 2. Week 4 3. 3 months 4. 6 months 5. 12 months 6. Extra study visits can be planned as deemed necessary for the individual participant between the above outlined visits Weekly visits in the clinic for bandage changes and standard wound care is planned as deemed relevant by the MDT team for the individual participant. The visits are performed by wound care nurses in the primary sector If any outcomes relevant for the study occurs outside of the planned study visits i.e., ulcer healing, infections or recurrence following
Participants randomized to control are not invited to be seen by the MDT team but are attended by the wound care nurse from the primary sector as part of the standard treatment offered to individuals with ulcers in the municipality. Apart from planned visits at 3, 6 and 12 months, the frequency and number of visits in the study period is performed as deemed appropriate by the wound care nurses from the primary sector. If any outcomes relevant for the study occurs outside of the planned study visits i.e., ulcer healing, infections or recurrence following healing date of event is noted.
Eligibility Criteria
You may qualify if:
- Patients aged 18 years or above
- Hard-to-heal ulcer(s)
- Able to understand written and oral information
- Ability to follow planned visits and treatment
- Able to provide informed consent in Danish and/or English
You may not qualify if:
- Revascularization procedure in the affected limb planned, or undertaken within the 4 weeks prior to screening
- Toe blood pressure \< 35mmHg
- Infections of the ulcer needing acute or sub-acute (defined as within seven days) surgical treatment
- Prior major amputations on affected or contralateral leg
- Current treatment with cytotoxic drugs or with systemically administered glucocorticoids
- Likely inability to comply with the need for planned visits because of planned activities
- Participation in another interventional ulcer-healing trial within the 4 weeks prior to screening
- Prior enrolment in this trial
- Judgement by the investigator that the patient does not have the capacity to understand the study procedures or provide written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nordsjaellands Hospitallead
- Frederikssund Municipality, Denmarkcollaborator
Study Sites (1)
North Zealand Hospital
Hillerød, 3400, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD Phd Clin Assoc Prof
Study Record Dates
First Submitted
July 9, 2026
First Posted
August 5, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
April 30, 2027
Study Completion (Estimated)
October 31, 2028
Last Updated
August 5, 2026
Record last verified: 2026-07